<i>Trichosporon asahii</i> superinfections in critically ill COVID‐19 patients overexposed to antimicrobials and corticosteroids

João Nóbrega de Almeida(Universidade Federal de São Paulo), Arnaldo Lopes Colombo(Universidade Federal de São Paulo), Lis Moreno(D’Or Institute for Research and Education), Elaine Cristina Francisco(Universidade Federal do Paraná), Ana Verena Almeida Mendes(Escola Bahiana de Medicina e Saúde Pública), Gabriela Noronha Marques(Hospital São Rafael), Maria Goreth Barberino(Hospital São Rafael)

Mycoses

June 6, 2021

10.1111/myc.13333

Cited by 36

Related Papers

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

|The Lancet|2020|5k

Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium

|The Lancet Infectious Diseases|2019|1.7k

Simultaneous Emergence of Multidrug-Resistant <i>Candida auris</i> on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses

|Clinical Infectious Diseases|2016|1.6k

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

|The Lancet|2021|1.2k

Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study

|The Lancet|2022|467